Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Interest Coverage Ratio: 2021-2025

Historic Interest Coverage Ratio for Autolus Therapeutics (AUTL) over the last 4 years, with Sep 2025 value amounting to -6.81.

  • Autolus Therapeutics' Interest Coverage Ratio fell 7.18% to -6.81 in Q3 2025 from the same period last year, while for Sep 2025 it was 16.11, marking a year-over-year increase of 617.32%. This contributed to the annual value of -25.98 for FY2024, which is 551.46% down from last year.
  • Autolus Therapeutics' Interest Coverage Ratio amounted to -6.81 in Q3 2025, which was down 175.95% from 8.96 recorded in Q2 2025.
  • Over the past 5 years, Autolus Therapeutics' Interest Coverage Ratio peaked at 8.96 during Q2 2025, and registered a low of -21.58 during Q2 2022.
  • Moreover, its 3-year median value for Interest Coverage Ratio was -6.35 (2024), whereas its average is -3.92.
  • Examining YoY changes over the last 5 years, Autolus Therapeutics' Interest Coverage Ratio showed a top increase of 254.77% in 2025 and a maximum decrease of 219.78% in 2025.
  • Quarterly analysis of 5 years shows Autolus Therapeutics' Interest Coverage Ratio stood at -20.85 in 2021, then surged by 83.84% to -3.37 in 2022, then spiked by 47.53% to -1.77 in 2023, then surged by 239.15% to 2.46 in 2024, then dropped by 7.18% to -6.81 in 2025.
  • Its last three reported values are -6.81 in Q3 2025, 8.96 for Q2 2025, and -6.43 during Q1 2025.